WHY NOT EXOSOMES OR MIXED BIOLOGICS?

Many products marketed as “regenerative” rely on exosomes or undefined biological mixtures. From a medical and regulatory standpoint, these approaches have fundamental limitations: Exosomes are heterogeneous vesicles with variable and undefined cargo. Composition varies by donor source, culture conditions, and isolation method. Dosing and signalling are inconsistent and difficult to reproduce. Nano-scale size allows uncontrolled systemic distribution. Long-term safety and regulatory pathways remain uncertain. In contrast, ReGen Factor’s bio-identical bFGF is: A single, fully defined molecule Structurally identical to native human bFGF Locally active at the treatment site Rapidly degraded after signalling Fully characterisable and reproducible Regeneration requires precision, not biological noise.